EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Development and Validation of the Nonalcoholic Fatty Liver Disease Familial Risk Score to Detect Advanced Fibrosis: A Prospective, Multicenter Study

Daniel Q Huang, Noora Ahlholm, Panu K Luukkonen, Kimmo Porthan, Maral Amangurbanova, Egbert Madamba, Richele Bettencourt, Harris Siddiqi, Vanessa Cervantes, Christie Hernandez, Scarlett J Lopez, Lisa Richards und 4 weitere

Clinical Gastroenterology and Hepatology · 2024

DOI: 10.1016/j.cgh.2023.06.020 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Clinical Gastroenterology and Hepatology, 2024. Verfasst von Daniel Q Huang und 15 weiteren Autor:innen. Beteiligte Einrichtung: Nonalcoholic Fatty Liver Disease Research Center, Division of Gastroenterology and Hepatology, Department of Medicine, University of California San D…. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NCATS NIH HHS, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND & AIMS: Nonalcoholic fatty liver disease (NAFLD)-related fibrosis is heritable, but it is unclear how family history may be used to identify first-degree relatives with advanced fibrosis. We aimed to develop and validate a simple risk score to identify first-degree relatives of probands who have undergone assessment of liver fibrosis who are at higher risk of NAFLD with advanced fibrosis. METHODS: This prospective, cross-sectional, familial study consisted of a derivation cohort from San Diego, California, and a validation cohort from Helsinki, Finland. This study included consecutive adult probands (n = 242) with NAFLD and advanced fibrosis, NAFLD without advanced fibrosis, and non-NAFLD, with at least 1 of their first-degree relatives. All included probands and first-degree relatives underwent evaluation of liver fibrosis, the majority by magnetic resonance elastography. RESULTS: A total of 396 first-degree relatives (64% male) were included. The median age and body mass index were 47 years (interquartile range, 32-62 y) and 27.6 kg/m2 (interquartile range, 24.1-32.5 kg/m2), respectively. Age (1 point), type 2 diabetes (1 point), obesity (2 points), and proband with NAFLD and advanced fibrosis (2 points) were predictors of advanced fibrosis among first-degree relatives in the derivation cohort (n = 220) and formed the NAFLD Familial Risk Score. The area under the receiver operator characteristic curve of the NAFLD Familial Risk Score for detecting advanced fibrosis was 0.94 in the validation cohort (n = 176). The NAFLD Familial Risk Score outperformed the Fibrosis-4 index in the validation cohort (area under the receiver operator characteristic curve, 0.94 vs 0.70; P = .02). CONCLUSIONS: The NAFLD Familial Risk Score is a simple and accurate clinical tool to identify advanced fibrosis in first-degree relatives. These data may have implications for surveillance in NAFLD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Non-alcoholic Fatty Liver DiseaseDiabetes Mellitus, Type 2AdultHumansMaleFemaleCross-Sectional StudiesProspective StudiesRisk FactorsLiver CirrhosisGenetic Predisposition to DiseaseLiverBiopsy

Stichwörter der Autor:innen

FibrosisGenetic FactorsHeritabilityNonalcoholic Fatty Liver Disease (NAFLD)

Autor:innen und Institutionen

  • Nonalcoholic Fatty Liver Disease Research Center, Division of Gastroenterology and Hepatology, Department of Medicine, University of California San Diego, La Jolla, California; Department of Medicine, Yong Loo Lin Schoo…
  • Department of Medicine, University of Helsinki, Helsinki University Hospital, Helsinki, Finland; Minerva Foundation Institute for Medical Research, Helsinki, Finland.
  • Nonalcoholic Fatty Liver Disease Research Center, Division of Gastroenterology and Hepatology, Department of Medicine, University of California San Diego, La Jolla, California.
  • Department of Medicine, University of Helsinki, Helsinki University Hospital, Helsinki, Finland; Transplantation and Liver Surgery Unit, Abdominal Center, University of Helsinki, Helsinki University Hospital, Helsinki,…
  • Transplantation and Liver Surgery Unit, Abdominal Center, University of Helsinki, Helsinki University Hospital, Helsinki, Finland.
  • Nonalcoholic Fatty Liver Disease Research Center, Division of Gastroenterology and Hepatology, Department of Medicine, University of California San Diego, La Jolla, California; Division of Gastroenterology and Hepatolog…

Förderung

  • NIDDK NIH HHS
  • NCATS NIH HHS
  • NHLBI NIH HHS
  • National Medical Research Council
  • National Heart, Lung, and Blood Institute
  • Ministry of Health -Singapore
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • Academy of Finland

Zitieren

APA

Huang, D. Q., Ahlholm, N., Luukkonen, P. K., Porthan, K., Amangurbanova, M., Madamba, E., Bettencourt, R., Siddiqi, H., Cervantes, V., Hernandez, C., Lopez, S. J., Richards, L., Nemes, K., Isoniemi, H., Yki-Järvinen, H., & Loomba, R. (2024). Development and Validation of the Nonalcoholic Fatty Liver Disease Familial Risk Score to Detect Advanced Fibrosis: A Prospective, Multicenter Study. Clinical Gastroenterology and Hepatology. https://doi.org/10.1016/j.cgh.2023.06.020

Vancouver

Huang DQ, Ahlholm N, Luukkonen PK, Porthan K, Amangurbanova M, Madamba E, et al. Development and Validation of the Nonalcoholic Fatty Liver Disease Familial Risk Score to Detect Advanced Fibrosis: A Prospective, Multicenter Study. Clinical Gastroenterology and Hepatology. 2024. doi:10.1016/j.cgh.2023.06.020

BibTeX
@article{Huang2024,
  author = {Huang, Daniel Q and Ahlholm, Noora and Luukkonen, Panu K and Porthan, Kimmo and Amangurbanova, Maral and Madamba, Egbert and Bettencourt, Richele and Siddiqi, Harris and Cervantes, Vanessa and Hernandez, Christie and Lopez, Scarlett J and Richards, Lisa and Nemes, Katriina and Isoniemi, Helena and Yki-Järvinen, Hannele and Loomba, Rohit},
  title = {Development and Validation of the Nonalcoholic Fatty Liver Disease Familial Risk Score to Detect Advanced Fibrosis: A Prospective, Multicenter Study},
  journal = {Clinical Gastroenterology and Hepatology},
  year = {2024},
  doi = {10.1016/j.cgh.2023.06.020}
}
Kostenlos starten →